Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$275K Buy
4,088
+234
+6% +$15.6K 0.01% 475
2026
Q1
$242K Buy
+3,854
New +$268K 0.01% 508
2020
Q3
Sell
-4
Closed 413
2020
Q2
$0 Hold
4
﹤0.01% 1092
2020
Q1
$0 Sell
4
-8
-67% -$498 ﹤0.01% 1034
2019
Q4
$1K Buy
+12
New +$569 ﹤0.01% 927

Other funds holding DXCM

Procyon Advisors's DXCM Position: Q2 2026 in Review

Procyon Advisors increased its DexCom (DXCM) stake by 6.1% in Q2 2026, buying an estimated $15.6K and bringing the position to 4,088 shares worth $275K. The position accounts for 0.01% of the portfolio, ranked #475.

Procyon Advisors first reported a position in DXCM in Q4 2019 and has held it in 5 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Procyon Advisors held 4,088 shares of DexCom worth $275K as of Q2 2026.
  • Procyon Advisors bought 234 DexCom shares in Q2 2026, an estimated $15.6K.
  • DexCom made up 0.01% of Procyon Advisors's portfolio in Q2 2026, its #475 holding.
  • Procyon Advisors first reported a position in DexCom in Q4 2019 and has held it in 5 quarters since.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Procyon Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.